Notice Regarding Absorption-type merger of Shionogi Pharma Co., Ltd.| SHIONOGI

OSAKA, Japan, October 27, 2025 – Shionogi & Co., Ltd.  (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi” or the “Company”) announced that at the Board of Directors meeting held today, it was…

Continue Reading